Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers
A Phase 1 Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers
Sponsor: Surface Oncology
This PHASE1 trial investigates Advanced Solid Cancers and Hematologic Cancers and is currently completed. Surface Oncology leads this study, which shows 10 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Feb 2020 — Nov 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Dec 2018 — Feb 2020 [monthly]
Recruiting PHASE1
-
Oct 2018 — Dec 2018 [monthly]
Recruiting PHASE1
-
Aug 2018 — Oct 2018 [monthly]
Recruiting PHASE1
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE1
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE1
First recorded
Mar 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Surface Oncology
For direct contact, visit the study record on ClinicalTrials.gov .